Daniela Francisci - Concepedia

Author

Daniela Francisci

Also Known As

Annalia Asti, D Francisci, D. Francisci, Daniela Francisci, E. Rubino, F. Baldelli, F. Sabbatini, F. Savalli, Francisci D, Gian Piero Caldarelli

103

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

University of Perugia Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani University of Milan Ospedale San Paolo Luigi Sacco Hospital

About

Daniela Francisci is an author at University of Perugia specializing in hiv, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	234
2	Immunology	5	5	115
3	Public Health	4	4	91
4	Epidemiology	4	4	79
5	Hepatology	2	2	27

Daniela Francisci

Publications

Citations

H-Index

Page 1

	Year	Citations
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Chiara Fallerini, Sergio Daga, Stefania Mantovani, eLife	2021	207
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quirós-Roldán, Journal of Antimicrobial Chemotherapy	2016	75
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients Stefania Mantovani, Sergio Daga, Chiara Fallerini, Genes and Immunity	2021	75
A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease Marco Floridia, Raffaella Bucciardini, D. Ricciardulli, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ImmunologyPharmacotherapyAntiviral DrugHiv/aids CounsellingTriple Combination	1999	55
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry Laura Galli, Maria Rita Parisi, Andrea Poli, Open Forum Infectious Diseases	2020	50
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues Matteo D’Antonio, Jennifer Nguyen, Timothy D. Arthur, Cell Reports	2021	46
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort Annalisa Saracino, P Lorenzini, Sergio Lo Caputo, Clinical Microbiology and Infection Virologic FailurePreventive MedicineEpidemiological OutcomeTreatment And PreventionHiv-infected Migrants	2015	44
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial Stefano Rusconi, Paola Vitiello, Fulvio Adorni, PLoS ONE	2013	41
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study Mattia Prosperi, Nicola Mackie, Simona Di Giambenedetto, Journal of Antimicrobial Chemotherapy	2011	41
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial Massimiliano Fabbiani, Roberta Gagliardini, Nicoletta Ciccarelli, Journal of Antimicrobial Chemotherapy	2018	32

Page 1